ESR1 and breast carcinoma: Estrogen also binds with the estrogen receptors (ERs) in ER+ breast cancers (more than 70% of breast cancers) to inhibit tumor cell autophagy and deregulate the cell cycle which lead to BC tumorigenesis [102].